Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
8
×
san francisco blog main
san francisco top stories
8
×
biotech
boston blog main
deals
national top stories
new york blog main
san diego blog main
boston top stories
new york top stories
raleigh-durham blog main
san diego top stories
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
fda
san francisco
startups
alnylam pharmaceuticals
cancer
gene therapy
hemophilia
imara
investing
lung cancer
novartis
What
help
8
×
bio
drug
roundup
deal
expand
gene
long
medical
medicine
million
news
patients
therapy
treatment
acquisitions
adding
adu
aims
alzheimer's
analytics
announced
approved
aren’t
auris
bad
beats
bids
biofourmis
biogen
brain
cancer
case
ceo
clearance
collabs
company
complicated
covid
crude
Language
unset
Current search:
" national blog main "
×
" san francisco top stories "
×
help
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More